Cover Image

Diagnostic Value of Hepatic Vein Ultrasound in Early Detection of Liver Cirrhosis

Hadi Zare Marzouni, Behrooz Davachi, Mahdi Rezazadeh, Mahmoud Salehi Milani, Sedighe Matinfard

Background: Cirrhosis is a common disease that destroys liver cells, and it has various etiologies. The early diagnosis of cirrhosis can be effective in improving prognosis.

Considering the availability and affordability of ultrasound devices throughout the world, in this study we evaluated the diagnostic value of hepatic vein ultrasound examination in the early detection of liver cirrhosis.

Materials and Methods: In this study, 45 patients referred to the radiology department of Ghaem Hospital for liver biopsy were evaluated for changes in the hepatic veins under ultrasound with a transducer of 5-7MHz. One piece of the hepatic vein was selected for ultrasound, and the wall of hepatic veins was examined for straightness and uniformity of echogenicity. Subsequently, patients underwent biopsy by ultrasound guide.  Of all the study subjects, eight patients presented mild chronic hepatitis without fibrosis, four patients were diagnosed with fatty liver, and 33 patients had severe cirrhosis or chronic hepatitis with fibrosis.

Results: Our results showed that hepatitis patients with or without fibrosis had irregular and wavy hepatic vein wall (impairment in straightness) with non-uniform echo (impairment in uniformity of echogenicity). While patients without hepatitis and cirrhosis, but diagnosed with fatty liver, had a smooth and regular hepatic vein wall with a uniform echo.

Conclusion: The present study showed that hepatic vein examination in terms of echogenicity and straightness could be used to diagnose hepatitis, its severity as well as its course towards fibrosis and cirrhosis. [GMJ.2018;7:e1140]

Liver Cirrhosis; Hepatic Vein; Liver; Sonography

Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol. 2007;61(1):57-69.

https://doi.org/10.1016/j.ejrad.2006.11.003

PMid:17145154

Razmgah GRG, Hosseini SM-R, Nematy M, Esmaily H, Yousefi M, Kamalinejad M et al. Efficacy of Traditional Persian Medicine-Based Diet on Non-Alcoholic Fatty Liver Disease: A Randomized, Controlled, Clinical Trial. GMJ. 2017;6(3):208-16.

Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol. 2017;31(3):239-47.

https://doi.org/10.1016/j.bpg.2017.05.008

PMid:28774405

Moosavy SH, Davoodian P, Nazarnezhad MA, Nejatizaheh A, Eftekhar E, Mahboobi H. Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electron Physician. 2017;9(10):5646-56.

https://doi.org/10.19082/5646

PMid:29238510 PMCid:PMC5718874

Wiklund RA. Preoperative preparation of patients with advanced liver disease. Crit Care Med. 2004;32(4):S106-S15. https://doi.org/10.1097/01.CCM.0000115624.13479.E6

PMid:15064669

Garcia‐Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310-35.

https://doi.org/10.1002/hep.28906

PMid:27786365

Bacon BR. Cirrhosis and its complications. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jamesons JL, editors Harrison's Principle of Internal Medicine 17th ed: McGraw Hill. 2008:1971-4.

Marzouni HZ, Bagherabad MB, Sharaf S, Zarrinkamar M, Shaban S, Aryan H et al. Thioredoxin Reductase Activity and Its Tissue Distribution in the Pathologic Specimens of Patients with Laryngeal Squamous Cell Carcinoma. GMJ. 2016;5(3):153-59.

Martínez-Noguera A, Montserrat E, Torrubia S, Villalba J, editors. Doppler in hepatic cirrhosis and chronic hepatitis. Seminars in Ultrasound, CT and MRI; 2002: Elsevier.

Wiegand J, Berg T. The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Deutsches Ärzteblatt International. 2013;110(6):85. https://doi.org/10.3238/arztebl.2013.0085

Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis. 2001;32(3):492-7.

https://doi.org/10.1086/318501

PMid:11170959

Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Postgrad Med J. 2008;84(998):662-70. https://doi.org/10.1136/gut.2006.107789

PMCid:PMC1954971

Liver EAFTSOT. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. J Hepatol. 2011;55(2):245-64.

https://doi.org/10.1016/j.jhep.2011.02.023

PMid:21371579

Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115(2):209. https://doi.org/10.1172/JCI24282

PMid:15690074 PMCid:PMC546435

Barakat M. Non-pulsatile hepatic and portal vein waveforms in patients with liver cirrhosis: concordant and discordant relationships. Br J Radiol. 2004;77(919):547-50.

https://doi.org/10.1259/bjr/19413822

PMid:15238399

Sugimoto H, Kaneko T, Hirota M, Tezel E, Nakao A. Earlier hepatic vein transit-time measured by contrast ultrasonography reflects intrahepatic hemodynamic changes accompanying cirrhosis. J Hepatol. 2002;37(5):578-83.

https://doi.org/10.1016/S0168-8278(02)00264-7

El-Serag HB, Marrero JA, Rudolph L, Reddy KR. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology. 2008;134(6):1752-63.

https://doi.org/10.1053/j.gastro.2008.02.090

PMid:18471552

Vessal S, Naidoo S, Hodson J, Stella DL, Gibson RN. Hepatic Vein Morphology. J Ultrasound Med. 2009;28(9):1219-27.

https://doi.org/10.7863/jum.2009.28.9.1219

PMid:19710220

Nishida T. Diagnosis and Clinical Implications of Diabetes in Liver Cirrhosis: A Focus on the Oral Glucose Tolerance Test. J Endocr Soc. 2017;1(7):886-96.

https://doi.org/10.1210/js.2017-00183

PMid:29264539 PMCid:PMC5686620

Bedossa P, Carrat F. Liver biopsy: the best, not the gold standard. J Hepatol. 2009;50(1):1-3.

https://doi.org/10.1016/j.jhep.2008.10.014

PMid:19017551

Wong VW-S, Chu WC-W, Wong GL-H, Chan RS-M, Chim AM-L, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409-15.

https://doi.org/10.1136/gutjnl-2011-300342

PMid:21846782

Maluf D, Stravitz R, Williams B, Cotterell A, Mas V, Heuman D, et al. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience. Transplant Proc. 2007;39(1):153-9.

https://doi.org/10.1016/j.transproceed.2006.10.029

PMid:17275495

Fujii S, Matsusue E, Kanasaki Y, Kanamori Y, Nakanishi J, Sugihara S et al. Detection of peritoneal dissemination in gynecological malignancy: evaluation by diffusion-weighted MR imaging. Eur Radiol. 2008;18(1):18-23.

https://doi.org/10.1007/s00330-007-0732-9

PMid:17701040

Pacifico L, Anania C, Martino F, Cantisani V, Pascone R, Marcantonio A et al. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology. 2010;52(5):1643-51.

https://doi.org/10.1002/hep.23890

PMid:20890890

Heidelbaugh JJ, Bruderly M. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation. Am Fam Physician. 2006;74(5):756-62. PMid:16970019

Colli A, Fraquelli M, Andreoletti M, Marino B, Zuccoli E, Conte D. Severe liver fibrosis or cirrhosis: accuracy of US for detection—analysis of 300 cases. Radiology. 2003;227(1):89-94.

https://doi.org/10.1148/radiol.2272020193

PMid:12601199

Nehra MS, Ma Y, Clark C, Amarasingham R, Rockey DC, Singal AG. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol. 2013;47(5):e50.

https://doi.org/10.1097/MCG.0b013e3182688d2f

PMid:23090041 PMCid:PMC3556340

Refbacks

  • There are currently no refbacks.